Prestige Consumer Healthcare (PBH) Amortizatization of Intangibles (2010 - 2015)
Prestige Consumer Healthcare's (PBH) quarterly Amortizatization of Intangibles came in at $750000.0 in Q1 2015, up 154.24% year-on-year from $295000.0 in Q1 2014, and up 15.56% quarter-over-quarter from $649000.0 in Q4 2014.
Prestige Consumer Healthcare (PBH) Amortizatization of Intangibles (2010 - 2015) Analysis & Trends
Prestige Consumer Healthcare's Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $750000.0 for Q1 2015.
- On a quarterly basis, Amortizatization of Intangibles rose 154.24% year-over-year to $750000.0 in Q1 2015; TTM through Mar 2015 was $2.1 million, a 38.83% decrease from a year earlier, with the FY2015 full-year figure at $2.1 million, down 38.83% from the prior year.
- Amortizatization of Intangibles rose to $750000.0 in Q1 2015 per PBH's latest filing, from $649000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $3.1 million in Q4 2012 and bottomed at $144000.0 in Q2 2014.
- The 5-year median for Amortizatization of Intangibles is $404000.0 (2012), against an average of $669411.8.
- Across the five-year window, Amortizatization of Intangibles surged 1244.98% in 2012 and slumped 71.99% in 2014, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $229000.0 in 2011, then jumped by 1244.98% to $3.1 million in 2012, then decreased by 24.77% to $2.3 million in 2013, then slumped by 71.99% to $649000.0 in 2014, then rose by 15.56% to $750000.0 in 2015.
- Per Business Quant, the three latest PBH Amortizatization of Intangibles figures stand at $750000.0 (Q1 2015), $649000.0 (Q4 2014), and $543000.0 (Q3 2014).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Prestige Consumer Healthcare | 2.41 Bn | 2.35 Bn | 157.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 750,000.00 |
| Mar 31, 2015 | 750,000.00 |
| Dec 31, 2014 | 649,000.00 |
| Dec 31, 2014 | 649,000.00 |
| Sep 30, 2014 | 543,000.00 |
| Sep 30, 2014 | 543,000.00 |
| Jun 30, 2014 | 144,000.00 |
| Jun 30, 2014 | 144,000.00 |
| Mar 31, 2014 | 295,000.00 |
| Mar 31, 2014 | 295,000.00 |
| Dec 31, 2013 | 2.32 Mn |
| Dec 31, 2013 | 2.32 Mn |
| Sep 30, 2013 | 453,000.00 |
| Sep 30, 2013 | 453,000.00 |
| Jun 30, 2013 | 345,000.00 |
| Jun 30, 2013 | 345,000.00 |
| Mar 31, 2013 | 740,000.00 |
| Mar 31, 2013 | 740,000.00 |
| Dec 31, 2012 | 3.08 Mn |
| Dec 31, 2012 | 3.08 Mn |